Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from Alfresa Holdings ( (JP:2784) ).
Alfresa Holdings reported a 3.6% increase in net sales for the fiscal year ended March 31, 2025, reaching ¥2,961,051 million. However, the company experienced a decline in operating profit by 1.0% and a 7.3% decrease in profit attributable to owners of the parent. The cash flow from operating activities significantly decreased, and the annual dividend per share was reduced from the previous year. These financial results indicate challenges in maintaining profitability despite increased sales, potentially impacting stakeholders and market positioning.
The most recent analyst rating on (JP:2784) stock is a Hold with a Yen2500.00 price target. To see the full list of analyst forecasts on Alfresa Holdings stock, see the JP:2784 Stock Forecast page.
More about Alfresa Holdings
Alfresa Holdings Corporation operates within the healthcare industry, focusing on the distribution of pharmaceuticals, medical devices, and other healthcare-related products. The company is listed on the Prime Market of the Tokyo Stock Exchange.
Average Trading Volume: 511,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: Yen414.9B
See more data about 2784 stock on TipRanks’ Stock Analysis page.